Targeting PD‐L1 with DNA Aptamers and Conjugated with Gemcitabine as a Novel Therapeutic Strategy for Bladder Cancer Chemotherapy Combined with Immunotherapy
利用DNA适体靶向PD-L1并与吉西他滨偶联，作为一种新型膀胱癌化疗联合免疫疗法的治疗策略
期刊:Small Science
影响因子:8.3
doi:10.1002/smsc.202000069
Xu, Tong; Liang, Jie; Li, Shaoxiong; Xu, Zhaoquan; Yue, Luchao; Li, Tingshuai; Luo, Yonglan; Liu, Qian; Shi, Xifeng; Asiri, Abdullah M; Yang, Chun; Sun, Xuping; Hu, Xing; Zeng, Hongliang; Peng, Yongbo; Deng, Minhua; Xiang, Wei; Liu, Biao; Liu, Jiahao; Fu, Yunlong; Hu, Zhiqiang; Hou, Weibin; Liu, Xuewen; Tang, Jin; Long, Zhi; Wang, Long; Liu, Jianye
